Clinical Trial Update: Cnidium Monnieri Detoxification Formula for Persistent High-risk Human Papillomavirus Infection of Cervix. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for a Cnidium Monnieri detoxification formula targeting persistent high-risk HPV infection of the cervix; the study is not yet rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Human Papillomavirus Infection

Drugs mentioned

• Cnidium Monnieri Detoxification Formula

Snippet

Sponsor: Fudan University | Conditions: Human Papillomavirus (HPV) Infection, Cervical Cancer | Phase 2 | Status: NOT_YET_RECRUITING